Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic Discoveries
Open Access
- 1 March 2011
- journal article
- review article
- Published by Elsevier BV in Advances in Nutrition: An International Review Journal
- Vol. 2 (2), 78-88
- https://doi.org/10.3945/an.110.000109
Abstract
A concentration-function approach to vitamin C (ascorbate) has yielded new physiology and pharmacology discoveries. To determine the range of vitamin C concentrations possible in humans, pharmacokinetics studies were conducted. They showed that when vitamin C is ingested by mouth, plasma and tissue concentrations are tightly controlled by at least 3 mechanisms in healthy humans: absorption, tissue accumulation, and renal reabsorption. A 4th mechanism, rate of utilization, may be important in disease. With ingested amounts found in foods, vitamin C plasma concentrations do not exceed 100 μmol/L. Even with supplementation approaching maximally tolerated doses, ascorbate plasma concentrations are always μmol/L and frequently μmol/L. By contrast, when ascorbate is i.v. injected, tight control is bypassed until excess ascorbate is eliminated by glomerular filtration and renal excretion. With i.v. infusion, pharmacologic ascorbate concentrations of 25–30 mmol/L are safely achieved. Pharmacologic ascorbate can act as a pro-drug for hydrogen peroxide (H2O2) formation, which can lead to extracellular fluid at concentrations as high as 200 μmol/L. Pharmacologic ascorbate can elicit cytotoxicity toward cancer cells and slow the growth of tumors in experimental murine models. The effects of pharmacologic ascorbate should be further studied in diseases, such as cancer and infections, which may respond to generation of reactive oxygen species via H2O2.Keywords
This publication has 83 references indexed in Scilit:
- Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugsCancer Chemotherapy and Pharmacology, 2010
- Vitamins C and E to Prevent Complications of Pregnancy-Associated HypertensionThe New England Journal of Medicine, 2010
- Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic CancerClinical Cancer Research, 2010
- Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatmentFree Radical Biology & Medicine, 2009
- Oxalic acid excretion after intravenous ascorbic acid administrationMetabolism, 2009
- Vitamins E and C in the Prevention of Cardiovascular Disease in MenJAMA, 2008
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Efficacy of Parenteral Nutrition Supplemented With Glutamine Dipeptide to Decrease Hospital Infections in Critically Ill Surgical PatientsJournal of Parenteral and Enteral Nutrition, 2008
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Hydrogen Peroxide: A Signaling MessengerAntioxidants and Redox Signaling, 2006